UPDATE 5-Second J&J COVID-19 shot gets expert backing; FDA is looking at lowering age for Pfizer booster

After hearing presentations from J&J and FDA scientists, many members of the advisory panel asked if J&J's single-dose vaccine should actually be considered a two-dose shot for everyone. Reuters; October 17 ...

from Google Alert - Business https://ift.tt/3lVQj7b
After hearing presentations from J&J and FDA scientists, many members of the advisory panel asked if J&J's single-dose vaccine should actually be considered a two-dose shot for everyone. Reuters; October 17 ... https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize